Market Insights

Health insurers balk at Biogen's $56,000-a-year Alzheimer's treatment

Market Insights November 22, 2021 at 09:45 AM
Share & Print

More From HR Executive

NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Related Stories

Insurer participation in ACA Marketplaces goes down for first time Luigi Mangione plans psychiatric defense in UnitedHealthcare CEO killing case FDA approves Colorado's plan to import prescription drugs from Canada GLP-1s could lower lifetime medical spending by $12,000 Cigna's Express Scripts sues Tennessee over PBM law Health care costs projected to surge 9% in 2027